Action superstar Sylvester Stallone pulled plans for a proposed seaweed barrier next to his home, after hearing concerns from ...
MML Investors Services LLC trimmed its position in shares of Oxford Industries, Inc. (NYSE:OXM – Free Report) by 14.6% in the third quarter, HoldingsChannel reports. The firm owned 2,453 shares of the ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...
In addition to things branded with the Colony logo, there are other items that feature the Colony's wallpaper and color ...
Both Lilly and Novo Nordisk are experiencing unprecedented growth thanks to their weight loss medications. However, Lilly also treats cancer, plaque psoriasis, Alzheimer's disease, eczema ...
In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.
Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and only prescription medicine for adults with moderate ...
Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have attracted a lot of attention over the past two years thanks to their advances in the weight loss therapy market. Musk revealed using Novo ...
US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth platforms could violate federal anti-kickback laws. The four ...
After hours: December 27 at 7:51:26 p.m. EST ...